Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV-HCV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT06528626
What this trial is testing

Tools to Identify People At Risk or Already Infected with HIV and HCV

Who this might be right for
HIV/AIDSSTDHCV
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 240,000
Early research (Phase 1)Study completedNCT00489385
What this trial is testing

An Open Label Non-Randomized Dose Escalating Trial to Assess Safety and Tolerability of Alb-Interferon Alfa 2b Every Two Weeks With Ribavirin Among HIV/HCV Coinfected Individuals

Who this might be right for
HIV InfectionsHCV
National Institute of Allergy and Infectious Diseases (NIAID) 41
Large-scale testing (Phase 3)Study completedNCT02252016
What this trial is testing

Grazoprevir (MK-5172) and Elbasvir (MK-8742) Combination for Chronic Hepatitis C Virus (HCV) Genotypes 1, 4, and 6 (MK-5172-065)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 159
Post-approval studies (Phase 4)Study completedNCT01327547
What this trial is testing

Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B

Who this might be right for
HIV Coinfection
ViiV Healthcare 138
Not applicableStudy completedNCT00959166
What this trial is testing

To Assess Neuroinflammation and Neurocognitive Function in Patients With Acute Hepatitis C and Chronic HIV Co-Infection

Who this might be right for
Acute Hepatitis CHIVHIV Infections
Imperial College London 81
Post-approval studies (Phase 4)WithdrawnNCT01654939
What this trial is testing

Impact of an Antibiotic (Rifaximin) on Liver Scarring in HIV-Infected Patients With Liver Disease

Who this might be right for
HIVHepatitis C
Douglas T. Dieterich
Not applicableUnknownNCT00499434
What this trial is testing

Correlation Between Cytokines and Hepatic Histology in Patients Infected by HIV-1 and the Hepatitis-C Virus

Who this might be right for
Acquired Immune Deficiency SyndromeHepatitis, Viral, Non-A, Non-B, Parenterally-TransmittedHIV Infections
UPECLIN HC FM Botucatu Unesp 110
Not applicableStudy completedNCT00381992
What this trial is testing

Risk Assessment of Long-Haul Truck Drivers

Who this might be right for
GonorrheaChlamydia InfectionsHepatitis B+6 more
Wake Forest University Health Sciences 294
Not applicableStudy completedNCT01206933
What this trial is testing

The Effect of HIV Tat Protein on HCV Replication in an In-vitro Model System

Who this might be right for
Human Immunodeficiency Virus (HIV)Hepatitis C, Chronic
George Washington University 20
Testing effectiveness (Phase 2)Study completedNCT01878799
What this trial is testing

Study of A Combination Pill With GS-7977 and GS-5885 for Hepatitis C in People With HIV

Who this might be right for
Hepatitis CHIV
National Institute of Allergy and Infectious Diseases (NIAID) 50
Not applicableStudy completedNCT04033887
What this trial is testing

Evaluation Study of RDTs Detecting Antibodies Against HCV

Who this might be right for
Hepatitis C
Foundation for Innovative New Diagnostics, Switzerland 1,710
Testing effectiveness (Phase 2)Study completedNCT02124044
What this trial is testing

Safety, Tolerability, and Efficacy of Asunaprevir and Daclatasvir in Subjects Coinfected With HIV-HCV

Who this might be right for
HIV-HCV
National Institutes of Health Clinical Center (CC) 30
Post-approval studies (Phase 4)UnknownNCT01105611
What this trial is testing

Safety and Efficacy Study Comparing Raltegravir to a Protease Inhibitor in Treatment-naïve, HIV/Hepatitis C Drug Users

Who this might be right for
HIV InfectionsHepatitis C
St. James's Hospital, Ireland 40
Post-approval studies (Phase 4)Study completedNCT03823911
What this trial is testing

Cardiovascular Disease in HIV and Hepatitis C: Risk Outcomes After Hepatitis C Eradication

Who this might be right for
Cardiovascular DiseasesHepatitis CHiv
University of Maryland, Baltimore 87
Large-scale testing (Phase 3)Study completedNCT01006031
What this trial is testing

Retreatment With High Doses of pegIFN Alfa-2a and Ribavirin of Previous Nonresponders HIV-coinfected Patients With Cirrhosis Due to HCV 1-4

Who this might be right for
Liver CirrhosisHepatitis C VirusHIV Infection
Sociedad Andaluza de Enfermedades Infecciosas 25
Post-approval studies (Phase 4)Study completedNCT03250910
What this trial is testing

Generic VEL/SOF With or Without RBV for HIV/HCV Coinfected Patients

Who this might be right for
Hepatitis C Virus Infection, Response to Therapy ofHuman Immunodeficiency Virus
National Taiwan University Hospital 228
Not applicableUnknownNCT03407703
What this trial is testing

Hepatitis C (HCV) Cure and Kidney Health

Who this might be right for
Hepatitis C
San Francisco Veterans Affairs Medical Center 50
Not applicableStudy completedNCT02427204
What this trial is testing

Outcomes in Liver Disease Patient With and Without HIV Co-infection-Sub Study 2: HCV Treatment: Health Related Quality

Who this might be right for
Hepatitis C Infection
Icahn School of Medicine at Mount Sinai 150
Testing effectiveness (Phase 2)Study completedNCT04042740
What this trial is testing

Glecaprevir/Pibrentasvir Fixed-dose Combination Treatment for Acute Hepatitis C Virus Infection

Who this might be right for
Hepatitis C InfectionHIV Infection
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 45
Testing effectiveness (Phase 2)Looking for participantsNCT07681089
What this trial is testing

Foscenvivint in Liver Cirrhosis Patients Caused by HIV/HCV Co-infection With Hemophilia

Who this might be right for
Liver Cirrhosis
Kiminori Kimura, MD 4
Next Page